Endocrine System Diseases Clinical Trials

STUDY
CONDITIONS
INTERVENTIONS
LOCATIONS
LAST UPDATED
E
A Study of Two Doses of Dulaglutide (LY2189265) in Japanese Patients With Type 2 Diabetes
Recruiting
  • Diabetes Mellitus
  • +6 more
  • Nagoya, Aichi, Japan
  • +43 more
2022-04-06
Apr 6, 2022
E
A Study to Evaluate Tirzepatide (LY3298176) in Pediatric and Adolescent Participants With Type 2 Diabetes Mellitus Inadequately Controlled With Metformin or Basal Insulin or Both
Not yet recruiting
  • Type2 Diabetes
  • +7 more
  • Tirzepatide Dose 1
  • +2 more
  • Birmingham, Alabama
  • +59 more
2022-04-06
Apr 6, 2022
A
A Trial Investigating the Safety, Tolerability and Efficacy of TransCon PTH Administered Daily in Adults With Hypoparathyroidism
Active, not recruiting
  • Hypoparathyroidism
  • +2 more
  • TransCon PTH
  • Placebo
  • San Francisco, California
  • +20 more
2022-03-28
Mar 28, 2022
C
An Open-Label, FIH Study Evaluating the Safety and Tolerability of VCTX210A Combination Product in Subjects With T1D
Recruiting
  • Diabetes Mellitus
  • +6 more
  • VCTX210A unit
  • Edmonton, Alberta, Canada
  • +2 more
2022-04-01
Apr 1, 2022
D
Diamyd Administered Into Lymph Nodes in Individuals Recently Diagnosed With Type 1 Diabetes, Carrying the HLA DR3-DQ2 Haplotype
Recruiting
  • Diabetes Mellitus, Type 1
  • +10 more
  • Recombinant human glutamic acid decarboxylase (rhGAD65) formulated in Alhydrogel®
  • +2 more
  • Hradec Kralove, Czechia
  • +30 more
2022-03-17
Mar 17, 2022
G
A Study of TRPC5 Channel Inhibitor in Patients With Diabetic Nephropathy, Focal Segmental Glomerulosclerosis, and Treatment-Resistant Minimal Change Disease
Recruiting
  • Kidney Diseases
  • +10 more
  • Birmingham, Alabama
  • +75 more
2022-03-29
Mar 29, 2022
G
First-In-Human Study of GFB-024 in Healthy Overweight and Obese Participants, and Participants With Type 2 Diabetes - 2022
Completed
  • Kidney Diseases
  • +4 more
  • San Antonio, Texas
    Worldwide Clinical Trials
2022-03-24
Mar 24, 2022
H
Phase 1/2 Study of the Highly-selective RET Inhibitor, Pralsetinib (BLU-667), in Patients With Thyroid Cancer, Non-Small Cell Lung Cancer, and Other Advanced Solid Tumors
Active, not recruiting
  • RET-altered Non Small Cell Lung Cancer
  • +39 more
  • pralsetinib (BLU-667)
  • Phoenix, Arizona
  • +78 more
2022-03-16
Mar 16, 2022
S
A Study of Gemcitabine, Nab-paclitaxel, Capecitabine, Cisplatin, and Irinotecan in Metastatic Pancreatic Cancer
Recruiting
  • Adenocarcinoma
  • +9 more
  • Baltimore, Maryland
    Sidney Kimmel Comprehensive Cancer Center
2022-03-15
Mar 15, 2022
V
A Phase 2b, Study of Linsitinib in Subjects With Active, Moderate to Severe Thyroid Eye Disease (TED)
Not yet recruiting
  • Thyroid Eye Disease
  • +11 more
  • (no location specified)
2022-03-02
Mar 2, 2022
F
Digital Foot Self-Management Program for Older-Diabetes
Recruiting
  • Diabetes Mellitus
  • +4 more
  • A digital foot self-management program
  • Kaohsiung, Taiwan
    Fooyin University
2022-02-28
Feb 28, 2022
T
A BHI to Increase Hope Level and Stress Level of Parents With a CMC: a Feasibility Study
Recruiting
  • Child With Cancer
  • +3 more
  • Brief Hope Intervention
  • Hong Kong, China
    School of Nursing, The Hong Kong Polytechnic University
2022-02-25
Feb 25, 2022
A
A Trial Investigating the Safety, Tolerability and Efficacy of TransCon PTH in Adults With Hypoparathyroidism
Active, not recruiting
  • Hypoparathyroidism
  • +2 more
  • TransCon PTH
  • Placebo for TransCon PTH
  • Chicago, Illinois
  • +14 more
2022-03-02
Mar 2, 2022
R
Dissecting the IMpact of 11-OXygenated and Classic Androgens on Skeletal Muscle Insulin Sensitivity (DIMOXIS)
Recruiting
  • Polycystic Ovary Syndrome
  • +3 more
  • Dehydroepiandrosterone (DHEA)
  • 11-ketoandrostenedione (11KA4)
  • Dublin 9, Ireland
    Beaumont Hospital
2022-02-21
Feb 21, 2022
H
Dietary Patterns and Health Outcomes (Cardiovascular, Metabolic, Endocrine, Neurological, Skeletal Muscular, Cancer)
Active, not recruiting
  • Cardiovascular Diseases
  • +8 more
  • Dietary intake
  • (no location specified)
2022-02-28
Feb 28, 2022
U
Closed-loop Insulin Delivery In Type 1 Diabetes Pregnancies (CIRCUIT) - Internal Pilot
Recruiting
  • Type 1 Diabetes Mellitus
  • +4 more
  • Tandem t:slim X2 insulin pump with Control IQ technology
  • Calgary, Alberta, Canada
  • +1 more
2022-02-08
Feb 8, 2022
V
Testosterone Plus Finasteride Treatment After Spinal Cord Injury - 2021
Terminated
  • Spinal Cord Injury
  • +10 more
  • testosterone enanthate, finasteride
  • placebo
  • Tampa, Florida
  • +1 more
2022-02-07
Feb 7, 2022
S
Endocrine Changes and Their Correction in Heart and Lung Transplant Recipients and Donors
Active, not recruiting
  • Endocrine System Diseases
  • +5 more
  • Blood test
  • Budapest, Pest, Hungary
    Heart and Vascular Center
2022-01-07
Jan 7, 2022
A
A Trial to Compare the Efficacy and Safety of Once-weekly Lonapegsomatropin With Placebo and a Daily Somatropin Product in Adults With Growth Hormone Deficiency
Recruiting
  • Growth Hormone Deficiency
  • +2 more
  • Phoenix, Arizona
  • +58 more
2022-01-18
Jan 18, 2022
S
Endocrine Changes in Adults Undergoing Cardiac Surgery
Active, not recruiting
  • Endocrine System Diseases
  • +3 more
    • Budapest, Hungary
    • +2 more
    2022-01-07
    Jan 7, 2022
    U
    Assessing Benefits of Near Infrared Autofluorescence (NIRAF) Detection for Identifying Parathyroid Glands During Total Thyroidectomy
    Recruiting
    • Thyroid Neoplasms
    • +8 more
    • PTeye
    • Ann Arbor, Michigan
      The University of Michigan
    2022-01-05
    Jan 5, 2022
    A
    A Safety, Tolerability and Efficacy Study of TransCon hGH in Children With Growth Hormone Deficiency - 2019
    Completed
    Has Results
    • Growth Hormone Deficiency, Pediatric
    • +3 more
    • TransCon hGH
    • Birmingham, Alabama
    • +23 more
    2021-12-07
    Dec 7, 2021
    A
    A Phase 3 Trial of the Safety, Tolerability and Efficacy of TransCon hGH Weekly Versus Daily hGH in Children With Growth Hormone Deficiency (GHD) - 2019
    Completed
    Has Results
    • Growth Hormone Deficiency, Pediatric
    • +4 more
    • Once weekly subcutaneous injection of TransCon hGH
    • Once daily subcutaneous injection of Genotropin
    • Birmingham, Alabama
    • +52 more
    2021-12-06
    Dec 6, 2021
    A
    A Trial to Investigate Long Term Efficacy and Safety of Lonapegsomatropin in Adults With Growth Hormone Deficiency
    Recruiting
    • Adult Growth Hormone Deficiency
    • +2 more
    • Las Vegas, Nevada
      Ascendis Pharma Investigational Site
    2021-12-28
    Dec 28, 2021
    V
    Soluble Epoxide Hydrolase Inhibition and Insulin Resistance
    Recruiting
    • Diabetes Mellitus
    • +4 more
    • Nashville, Tennessee
      Vanderbilt University Medical Center
    2021-11-18
    Nov 18, 2021